Loading
Latest filing published 04 Dec 2025 for Xvivo Perfusion Aktiebolag, €3,868. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Kristoffer Nordström is a declared insider of Xvivo Perfusion Aktiebolag (finance chief), with filings sourced from Finansinspektionen. We count 2 filings; the first trade dates from 14 July 2025 and the latest from 3 December 2025.
The open-market record is one-sided, with 2 purchases worth €4,250 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 4 December 2025 came the latest disclosure, an open-market purchase for €3,868 in Xvivo Perfusion Aktiebolag. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations